Vixen Pharmaceuticals Private Limited
Pharmaceutical company manufacturing drugs, established in 2017, based in Haryana.
2017 | Kaithal, Haryana (India) | Active
Vixen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 31.77%
- Profit Growth 70.52%
- Ebitda 86.75%
- Net Worth -13.09%
- Total Assets -1.51%
About Vixen Pharmaceuticals
Vixen Pharmaceuticals Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2017 (Seven years and six months 18 days old ). Its registered office is in Kaithal, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naveen and Ravi serve as directors at the Company.
Company Details
- Location
Kaithal, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999HR2017PTC070308
- Company No.
070308
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2017
- Date of AGM
12 Aug 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Vixen Pharmaceuticals?
Board Members (2)
Financial Performance of Vixen Pharmaceuticals.
Vixen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 31.77% increase. The company also saw a substantial improvement in profitability, with a 70.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vixen Pharmaceuticals?
In 2020, Vixen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vixen Pharmaceuticals?
Unlock and access historical data on people associated with Vixen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vixen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vixen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.